Description

INDICAID Fentanyl Urine Drug Detection Test – Point of Care (POC)

The INDICAID Fentanyl Drug Detection Test is a rapid, point-of-care screening solution designed for the qualitative detection of fentanyl in human urine. This easy-to-use test delivers results in approximately 5 minutes, enabling healthcare providers and testing professionals to identify potential fentanyl exposure quickly and efficiently.

Each kit contains 25 individually packaged tests, making it ideal for clinics, addiction treatment programs, hospitals, law enforcement agencies, and workplace drug screening environments.

Key Features

• Rapid Results in 5 Minutes – Enables immediate screening decisions

• Point-of-Care Testing – No specialized laboratory equipment required

• 25 Tests Per Kit – Ideal for clinics and testing programs

• CLIA-Waived – Suitable for decentralized healthcare settings

• FDA 510(k) Cleared – Meets regulatory standards for diagnostic devices

• Sensitive Detection – 1 ng/mL cutoff for fentanyl screening

• Individually Packaged Tests – Foil pouches with desiccant for stability

• Professional Use – Designed for medical and diagnostic environments

Why Fentanyl Drug Screening Is Important

Fentanyl is a highly potent synthetic opioid, significantly stronger than many other opioids and associated with a high risk of overdose. Rapid detection is critical for monitoring exposure, supporting addiction treatment programs, and improving public health safety.

Point-of-care urine testing helps organizations:

• Quickly identify fentanyl exposure

• Support treatment monitoring in recovery programs

• Improve clinical decision-making

• Enable rapid response in emergency settings

• Strengthen workplace drug testing programs

Product Specifications

How the Test Works

The INDICAID Fentanyl Drug Detection Test uses lateral flow immunoassay technology to detect fentanyl compounds in urine samples.

1. A urine specimen is applied to the test device.

2. The sample migrates through the test strip via capillary action.

3. Antibodies specific to fentanyl interact with the sample.

4. Visible colored lines indicate whether fentanyl is detected.

The test provides preliminary screening results, and positive findings should be confirmed using laboratory methods such as GC/MS or LC/MS analysis.

Who Uses This Test?

This fentanyl urine detection kit is commonly used by:

• Healthcare providers

• Addiction recovery centers

• Hospitals and emergency departments

• Pain management clinics

• Occupational health teams

• Law enforcement agencies

• Public health programs monitoring substance use

Kit Contents

Each kit contains:

• 25 individually packaged fentanyl test devices

• Desiccant packets for stability

• Package insert with instructions for use

Each test is sealed in a foil pouch to maintain product integrity until use.

Storage & Shelf Life

To maintain optimal performance:

• Store at recommended room temperature conditions

• Keep tests sealed until ready to use

• Avoid excessive heat or humidity

Expiration Date: July 2026 for current inventory.